Who We Are

About Us

Management Team

Thomas G. Muehlbauer

CEO / President / Director / Founding Shareholder

Fortune 500 senior executive experience with over 25 Years of CEO and start-up skills including acquisitions, capital formation and public market transitions.

Prior to founding AVACEN in 2008, Mr. Muehlbauer started an Internet company which was sold to a publicly traded company bringing a return to founding investors of over 180% in 2 years. As a hands-on investor, he engineered the start-up growth and sale of World View, International, providing multimillion dollar returns to shareholders in less than a three-year period.

Mr. Muehlbauer developed his expertise in corporate management working for “Fortune 500” companies. Management positions ranged from Worldwide Data Center Manager, to President and CEO for three mid-sized corporations. He holds a Bachelor of Science, University State of New York.

Guy Sohie

COO and Director

Dr. Guy Sohie, Ph.D. has over 25 years of direct experience bringing medical device innovation to market. Dr. Sohie has lead all aspects of medical device innovation (Class I, II, and III), including product development and R&D, manufacturing, clinical studies, regulatory affairs and submissions, quality assurance, marketing, and M&A.
His experience ranges from large OEMs (GE Healthcare, GE Global Research, Johnson & Johnson) to early stage growth companies (e.g. Cardiac Science). Mr. Sohie served as Department Manager at General Electric Medical Systems (Europe), and R&D Project Manager at GE Corporate Research and Development. He was Senior Vice President at Cardiac Science, a leading defibrillator company; Managing Director at Artema Medical, a provider of patient monitoring technology; General Manager at Troniqa, a medical device contract manufacturer; Chief Operating Officer of Ventracor, an LVAD manufacturer; and Chief Operating Officer of VasoPrep Surgical, a vascular device startup.
Guy is trilingual (fluent in English, Dutch and French) and has global management experience in the United States, France, the United Kingdom, Sweden, Denmark, Belgium, and Australia. He has a Ph.D. in Acoustics Engineering from the Pennsylvania State University, where he was a Fulbright Scholar. He was elected to the honor Societies of Phi Kappa Phi, Eta Kappa Nu, and Sigma Xi and was a recipient of the General Electric Inventor Award at GE’s Corporate Research and Development Center. He received the Outstanding Contributions Award at Tech Coast Angels, a California based angel investor organization, where he also served as Fast Pitch Chairman.

Jeff Gray

Vice President Research & Development

MBA from Indiana University Kelley School of Business, a Master’s Degree in Engineering from Purdue University, and a Bachelor’s Degree in Electrical Engineering from San Diego State University. Over 20 years of management experience ranging from small startup companies to Fortune 100 firms.

Jeff has more than a decade of product development and operations management experience as President/Head of Technology for a test equipment manufacturing firm. He has performed in many managerial roles for a medical device manufacturer: product development, manufacturing, reliability engineering, and regulatory compliance (CareFusion – formerly Cardinal Health, Pyxis, and Alaris). Jeff also managed the test laboratory and staff for the North American operations of a European Notified Body.

He is a Certified Lean Six Sigma Black Belt. Jeff is the holder of two U.S. patents, with other patents pending.

Board Members

Thomas G. Muehlbauer

CEO / President / Director / Founding Shareholder

Fortune 500 senior executive experience with over 25 Years of CEO and start-up skills including acquisitions, capital formation and public market transitions.

Prior to founding AVACEN in 2008, Mr. Muehlbauer started an Internet company which was sold to a publicly traded company bringing a return to founding investors of over 180% in 2 years. As a hands-on investor, he engineered the start-up growth and sale of World View, International, providing multimillion dollar returns to shareholders in less than a three-year period.

Mr. Muehlbauer developed his expertise in corporate management working for “Fortune 500” companies. Management positions ranged from Worldwide Data Center Manager, to President and CEO for three mid-sized corporations. He holds a Bachelor of Science, University State of New York.

Guy Sohie

COO / Director

Dr. Guy Sohie, Ph.D. has over 25 years of direct experience bringing medical device innovation to market. Dr. Sohie has lead all aspects of medical device innovation (Class I, II, and III), including product development and R&D, manufacturing, clinical studies, regulatory affairs and submissions, quality assurance, marketing, and M&A.

His experience ranges from large OEMs (GE Healthcare, GE Global Research, Johnson & Johnson) to early stage growth companies (e.g. Cardiac Science). Mr. Sohie served as Department Manager at General Electric Medical Systems (Europe), and R&D Project Manager at GE Corporate Research and Development. He was Senior Vice President at Cardiac Science, a leading defibrillator company; Managing Director at Artema Medical, a provider of patient monitoring technology; General Manager at Troniqa, a medical device contract manufacturer; Chief Operating Officer of Ventracor, an LVAD manufacturer; and Chief Operating Officer of VasoPrep Surgical, a vascular device startup.

Guy is trilingual (fluent in English, Dutch and French) and has global management experience in the United States, France, the United Kingdom, Sweden, Denmark, Belgium, and Australia. He has a Ph.D. in Acoustics Engineering from the Pennsylvania State University, where he was a Fulbright Scholar. He was elected to the honor Societies of Phi Kappa Phi, Eta Kappa Nu, and Sigma Xi and was a recipient of the General Electric Inventor Award at GE’s Corporate Research and Development Center. He received the Outstanding Contributions Award at Tech Coast Angels, a California based angel investor organization, where he also served as Fast Pitch Chairman.

Danielle J Forsgren

VP Sales & Marketing/ Director / Founder

Danielle has over 30 years of experience in sales and marketing. She has extensive theatre, radio, public speaking and TV experience including multiple appearances on QVC. As the Company’s top sales person and Vice President of Sales & Marketing, she is currently developing several strategic initiatives to globally expand sales. Her efforts of the last 3 years have placed the Company on the INC. 5000 list of fastest growing companies in the US.  She studied at the International University and the University of San Diego.

James Wangler

Director / Founding Shareholder

M.S. – San Diego State University. President and CEO experience in addition to extensive engineering and engineering management experience. President and CEO of MAXIM Systems until sold in December 2007 to Accenture. Prior to MAXIM Mr. Wangler served as Chief Engineer for the ISR Directorate of SPAWAR Headquarters where he also served as the Program Manager for a $200 million Space Surveillance program.

Don Miller

Director

B.S. in Business Administration from the University of Kansas and a M. S. in Finance from San Diego State University. Mr. Miller, a former Naval officer, was co-founder and Sr. V.P. of SeQual Technologies, a San Diego based medical device company.  He was also an early stage investor, Board member, and CFO for the numerous companies in San Diego.

Fredrick P. Waid

Director

A graduate of Baylor Law School and Brigham Young University – Fred focuses primarily in the areas of trust and estate administration, real estate, banking, and corporate governance matters. He serves as a trustee, executor and special administrator of complex trusts and estates, by private and court appointment. Fred has been appointed by state and federal courts as a receiver, special servicer and interim corporate officer.

Advisors

Jonathan Lakey

Medical Research

Dr. Jonathan Lakey’s primary research direction has been cell and tissue transplantation, with a focus on diabetes and islet transplantation including efforts in developing alternative sources of insulin producing cells through stem cell differentiation and sourcing using porcine islets. Dr Lakey is also developing novel methods of protecting islets using biomaterials. Dr. Lakey graduated from the University of Alberta and received additional post-doctoral training in Indianapolis and Seattle before returning to establish his research program at the University of Alberta, Edmonton. There his partnership with Dr. James Shapiro led to improved islet isolation techniques and development of the “Edmonton Protocol,” a recognized major advance in the treatment of Type 1 diabetes. Dr. Lakey is now the Director of Research and Associate Professor of Surgery and Biomedical Engineering at the University of California, Irvine, and Director of the Clinical Islet Program.

Pamela Jackson

Military Government

Pamela brings decades of experience at operational and executive levels for various medical device companies. Pamela served as Vice President of Operations of startup – inVENTive Technologies – now owned by Philips. Most recently she served for 10 years as a Senior Director for SeQual Technologies, providing government and military development expertise for a diverse range of products. Her efforts resulted in numerous multimillion dollar research and development grants. Bachelor of Science, University of Massachusetts. She currently is COO for Panakeia marketing products to the military health system.

Experience the future of pain relief.

IT WORKS

Bas Rutten Shares His AVACEN Experience

Bas Rutten, UFC Heavyweight Champion, a three-time King of Pancrase World Champion, and finished his career on a 22 fight unbeaten streak. Bas has been using the AVACEN 100 to help reduce the pain and inflammation related to his joint, muscle, and nerve injuries. Bas has also been using AVACEN before, during, and after stem cell therapy…

TESTIMONIAL

CSI: Miami Star Sofia Milos shares her AVACEN Success Story.

FDA-Cleared, over-the-counter, non-invasive medical device that provides temporary relief for arthritis, muscle and joint pain; and muscle relaxation without a prescription, from the comfort of your own home.

After using the AVACEN 100, I can play the piano again.

Gabrielle F.Santa Barbara, CA

The first time I used it, I thought, ‘This cannot be true.’ The pain was actually gone!

Stephanie F.Las Vegas, NV

Read a book, watch the news, have a cup of coffee. It works

Cathy E.Poway, CA

After using the AVACEN 100, I can play the piano again.

Gabrielle F.Santa Barbara, CA

The first time I used it, I thought, ‘This cannot be true.’ The pain was actually gone!

Stephanie F.Las Vegas, NV

Read a book, watch the news, have a cup of coffee. It works

Cathy E.Poway, CA

Experience the future of pain relief.